Kaminska K, Akrap N, Staaf J, Alves CL, et al. Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer. Breast Cancer Res 2021;23:26.
PMID: 33602273